Panagora Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.6M Sell
822,114
-667,070
-45% -$53.4M 0.19% 115
2025
Q4
$142M Buy
1,489,184
+644,314
+76% +$63.2M 0.5% 39
2025
Q3
$82.5M Buy
844,870
+176,981
+26% +$18.3M 0.33% 68
2025
Q2
$71.7M Sell
667,889
-443,488
-40% -$44.9M 0.32% 77
2025
Q1
$112M Buy
1,111,377
+167,844
+18% +$16.9M 0.56% 36
2024
Q4
$84.3M Buy
943,533
+183,011
+24% +$16.1M 0.39% 57
2024
Q3
$63.7M Sell
760,522
-517,965
-41% -$40.8M 0.3% 88
2024
Q2
$98.5M Buy
1,278,487
+916,891
+254% +$67.1M 0.5% 50
2024
Q1
$24.8M Buy
361,596
+299,917
+486% +$19.3M 0.13% 149
2023
Q4
$3.57M Buy
61,679
+2,535
+4% +$135K 0.02% 399
2023
Q3
$3.12M Buy
59,144
+2,446
+4% +$128K 0.02% 413
2023
Q2
$3.07M Hold
56,698
0.02% 430
2023
Q1
$2.84M Sell
56,698
-13,939
-20% -$657K 0.02% 488
2022
Q4
$3.27M Sell
70,637
-520
-0.7% -$22.5K 0.02% 480
2022
Q3
$2.76M Buy
71,157
+2,430
+4% +$97.5K 0.02% 520
2022
Q2
$2.56M Buy
68,727
+1,255
+2% +$51.1K 0.02% 562
2022
Q1
$2.99M Buy
67,472
+27,250
+68% +$1.18M 0.02% 561
2021
Q4
$1.71M Sell
40,222
-9,024
-18% -$379K 0.01% 700
2021
Q3
$2.14M Sell
49,246
-688
-1% -$30.4K 0.01% 667
2021
Q2
$2.13M Sell
49,934
-2,423
-5% -$102K 0.01% 686
2021
Q1
$2.02M Sell
52,357
-13,999
-21% -$530K 0.01% 736
2020
Q4
$2.38M Buy
66,356
+12,499
+23% +$450K 0.01% 639
2020
Q3
$2.06M Sell
53,857
-31
-0.1% -$1.2K 0.01% 630
2020
Q2
$1.89M Sell
53,888
-2,624
-5% -$94.5K 0.01% 694
2020
Q1
$1.84M Sell
56,512
-608
-1% -$23.8K 0.01% 617
2019
Q4
$2.58M Buy
57,120
+493
+0.9% +$20.6K 0.01% 689
2019
Q3
$2.3M Sell
56,627
-714
-1% -$30.3K 0.01% 690
2019
Q2
$2.46M Buy
57,341
+280
+0.5% +$10.8K 0.01% 735
2019
Q1
$2.19M Sell
57,061
-3,537
-6% -$135K 0.01% 791
2018
Q4
$2.14M Sell
60,598
-25,240
-29% -$915K 0.01% 759
2018
Q3
$3.31M Buy
85,838
+20,821
+32% +$727K 0.01% 660
2018
Q2
$2.13M Sell
65,017
-2,745
-4% -$82.8K 0.01% 847
2018
Q1
$1.85M Sell
67,762
-22,016
-25% -$598K 0.01% 902
2017
Q4
$2.23M Buy
89,778
+29,044
+48% +$801K 0.01% 840
2017
Q3
$1.77M Sell
60,734
-18,846
-24% -$520K 0.01% 906
2017
Q2
$2.21M Sell
79,580
-106,143
-57% -$2.82M 0.01% 818
2017
Q1
$4.62M Buy
185,723
+78,813
+74% +$1.92M 0.02% 609
2016
Q4
$2.31M Sell
106,910
-4,827
-4% -$105K 0.01% 843
2016
Q3
$2.66M Sell
111,737
-351,704
-76% -$8.39M 0.01% 784
2016
Q2
$10.8M Sell
463,441
-265,918
-36% -$5.75M 0.05% 347
2016
Q1
$13.7M Sell
729,359
-2,691,406
-79% -$47.3M 0.07% 292
2015
Q4
$63.1M Sell
3,420,765
-660,122
-16% -$11.8M 0.31% 77
2015
Q3
$67M Sell
4,080,887
-550,825
-12% -$9.42M 0.35% 67
2015
Q2
$82M Buy
4,631,712
+403,677
+10% +$7.21M 0.41% 55
2015
Q1
$75M Sell
4,228,035
-372,429
-8% -$5.89M 0.38% 67
2014
Q4
$61M Sell
4,600,464
-1,833,656
-28% -$23.4M 0.31% 86
2014
Q3
$76M Buy
6,434,120
+782,988
+14% +$9.86M 0.37% 72
2014
Q2
$72.2M Buy
5,651,132
+695,270
+14% +$9.04M 0.35% 74
2014
Q1
$67M Sell
4,955,862
-769,843
-13% -$10.1M 0.32% 81
2013
Q4
$68.8M Buy
5,725,705
+1,641,575
+40% +$19.4M 0.32% 75
2013
Q3
$47.9M Sell
4,084,130
-1,696,029
-29% -$18.3M 0.24% 96
2013
Q2
$53.6M Buy
+5,780,159
New +$49M 0.27% 81

Other funds holding BSX

Panagora Asset Management's BSX Position: Q1 2026 in Review

Panagora Asset Management reduced its Boston Scientific (BSX) stake by 45% in Q1 2026, selling an estimated $53.4M and leaving 822,114 shares worth $51.6M. The position accounts for 0.19% of the portfolio, ranked #115.

Panagora Asset Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Panagora Asset Management held 822,114 shares of Boston Scientific worth $51.6M as of Q1 2026.
  • Panagora Asset Management sold 667,070 Boston Scientific shares in Q1 2026, an estimated $53.4M.
  • Boston Scientific made up 0.19% of Panagora Asset Management's portfolio in Q1 2026, its #115 holding.
  • Panagora Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Panagora Asset Management's Boston Scientific position peaked at $142M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.